Next Article in Journal
Dietary Therapies in Inflammatory Bowel Disease and Their Effects on Disease Activity and the Gut Microbiome
Previous Article in Journal
Dietary Leucine and Total Polyphenol Intake and Their Associations with Sarcopenia Indicators Among Older People Participating in the Program for Complementary Food in Older People (PACAM) in the Metropolitan Region, Santiago de Chile
Previous Article in Special Issue
Association of Maternal and Cord Blood Choline and Betaine Concentrations with Birthweight: A Prospective Mother–Infant Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preconception Folate Status, Dietary Intake, Supplementation, and Time to Pregnancy Among Women in a Premarital Health Examination Cohort

1
Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, School of Public Health, Peking University, Beijing 100191, China
2
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
3
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
4
State Key Laboratory of Female Fertility Promotion, Peking University, Beijing 100191, China
5
Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan 030001, China
6
Key Laboratory of Coal Environmental Pathogenicity and Prevention, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China
*
Authors to whom correspondence should be addressed.
Nutrients 2026, 18(14), 2238; https://doi.org/10.3390/nu18142238
Submission received: 28 April 2026 / Revised: 27 June 2026 / Accepted: 8 July 2026 / Published: 9 July 2026

Abstract

Background/Objectives: Folate plays a key role in one-carbon metabolism and may influence reproductive function, but evidence regarding its association with fecundability remains inconsistent. This study examined the association of folic acid (FA) supplementation, dietary folate intake, and folate status with time to pregnancy (TTP) among women planning to conceive. Methods: This study is a secondary analysis of a prospective cohort study included women enrolled during premarital health examinations in two counties in Shanxi Province (2009–2012). Folate-related exposures were assessed at baseline and included FA supplementation, dietary folate intake, and red blood cell (RBC) folate concentrations. Discrete-time proportional hazards model was used to estimate fecundability ratios (FRs) and 95% confidence intervals (CIs). Results: A total of 1475 women without a history of previous pregnancy were included, among whom 24 (1.6%) reported FA supplementation at baseline. Higher intake of several food groups was associated with increased RBC folate concentrations. In separate models, only seafood intake (1–3 times per week) was significantly associated with higher fecundability (FR: 1.23, 95% CI: 1.04, 1.44). In joint models, FA supplementation was associated with higher fecundability at 6 months (FR: 2.07, 95% CI: 1.01, 3.77), 12 months (FR: 1.91, 95% CI: 1.00, 3.30), and 24 months (FR: 1.91, 95% CI: 1.00, 3.30). Conclusions: Preconception FA supplementation showed a potential positive association with fecundability when considered alongside dietary intake and folate status, although the evidence was limited by the low use of supplementation. Further studies are needed to clarify the role of folate in human fecundability.

1. Introduction

Current studies have suggested that infertility remains a significant global public health concern. Approximately 8–12% of couples worldwide are affected, with prevalence reaching up to 30% in certain regions [1]. Time to pregnancy (TTP) is widely used as an indicator of fecundability, with a longer TTP reflecting a lower probability of conception and impaired reproductive potential [2]. Recent evidence from the United States suggests that TTP has increased over time, particularly among parous women and women older than 30 years [3]. Prolonged TTP can also impose substantial psychological stress on couples and negatively affect marital relationships.
Age is widely recognized as the most important determinant of TTP. Previous studies have reported an inverted U-shaped association between age and fertility, with peak reproductive potential occurring between 20 and 35 years [4,5]. Beyond age, multiple factors have been associated with TTP, including occupational exposures, history of pregnancy, body mass index (BMI), smoking, sleep patterns, work-related stressors, and metabolic syndrome [6,7,8,9,10,11,12,13]. Micronutrient status has also attracted increasing attention as a potentially modifiable determinant of reproductive function. A meta-analysis has reported that antioxidant supplementation may improve fertility in subfertile women and higher intakes of antioxidants such as β-carotene, vitamin C, and vitamin E have been linked to shorter TTP in couples undergoing infertility treatment [14,15].
Folate (vitamin B9) is an essential micronutrient during the preconception period and early pregnancy [16]. Folic acid (FA) supplementation is well-established in reducing the risk of neural tube defects (NTDs) and other adverse pregnancy outcomes [17]. Current guidelines recommend that women planning pregnancy consume 400 μg of FA daily from the preconception period through early pregnancy to ensure adequate folate status [18]. In addition, folate is a key component of one-carbon metabolism and is required for DNA synthesis, repair, and methylation [19]. Through these biological functions, adequate folate status may contribute to reproductive health and support successful conception [20]. However, evidence regarding folate and fecundability remains inconsistent. Prospective studies from Singapore and Denmark reported higher fecundability among women using FA supplements [21,22]. In contrast, other studies have observed no significant relationship between folate status and fecundability. These discrepancies may be partly explained by differences in study populations. For instance, some studies were conducted among folate-replete women with previous pregnancy loss [23], while in most other populations, FA supplementation is common, where the effect of folate may be less pronounced [24].
Given the inconsistent findings, a comprehensive evaluation of folate exposure is needed. Most previous studies have focused on a single dimension, such as supplementation or biomarker levels, which may not fully capture overall folate exposure. Therefore, this study aimed to explore the associations of FA supplementation, dietary folate intake, and folate status with TTP using data from a premarital examination cohort in northern China, with the goal of providing evidence to inform preconception health guidance and improve female fecundability.

2. Materials and Methods

2.1. Study Design

This study was based on a prospective cohort that was originally established to estimate infertility rates. Participants were recruited from women attending premarital health examinations at maternal and child health care centers in Xiyang County and Shouyang County, Shanxi Province, northern China, between November 2009 and July 2012. Eligible participants were women who were not pregnant at enrollment, intended to conceive within the following 12 months, planned to deliver locally, and provided informed consent. Women with a history of previous pregnancy, those who were already pregnant before marriage, and those without pregnancy intention were excluded from this study. The original cohort enrolled 2302 women, and after applying the eligibility criteria, 1475 women were included in the present analysis.

2.2. Assessment of Folate

In this premarital examination cohort, folate-related exposures were comprehensively assessed from three dimensions, including FA supplementation, dietary intake frequency, and biomarker-based folate status. All exposure information was collected at baseline before conception and prior to the initiation of follow-up.
Information on FA supplementation was obtained using a structured questionnaire, which assessed whether participants had used any FA-containing supplements during the past month. This variable was analyzed as a binary indicator (non-use vs. use).
Dietary folate intake was evaluated using a food frequency questionnaire covering the previous three months. From the surveyed food items, those included in the dietary folate frequency score were selected based on both nutritional relevance and statistical association with red blood cell (RBC) folate levels. For each food, intake frequency was classified into four categories: <1, 1–3, 4–6, or ≥7 times per week, corresponding to scores of 1 to 4, respectively. The overall dietary folate frequency score was calculated by summing the scores across all included food items, with higher scores indicating more frequent consumption of folate-rich foods.
Fasting venous blood samples were collected at recruitment. Plasma folate concentrations were measured using a microbiological assay. RBC folate concentrations were subsequently estimated using a previously validated equation based on the linear relationship between the natural logarithms of plasma and RBC folate (ln[RBC folate] = 0.54 × ln[plasma folate] + 4.85; R2 = 0.51, p < 0.0001) [25,26]. According to established cut-off values based on homocysteine-related metabolic criteria, RBC folate was categorized as deficiency (<340 nmol/L) or non-deficiency (≥340 nmol/L) [27].

2.3. Assessment of Covariates

Covariates included age at marriage (<25, 25–29, 30–34, and ≥35 years), BMI (<18.5, 18.5–23.9, and ≥24 kg/m2), based on the criteria recommended for Chinese adults, education (junior high school or below/high school or above), occupation (farmer, worker, and other), passive smoking exposure (no/yes), and residence (rural/urban).

2.4. Outcome Assessment

Participants were followed until conception or the end of available follow-up, resulting in varying follow-up durations across individuals. Among women who conceived, TTP was defined as the interval between initiation of attempts to conceive and the date of conception. For those who did not conceive, TTP was defined as the duration from initiation of pregnancy attempts to the last follow-up. Participants who did not conceive were treated as censored observations. For analysis, TTP was measured in discrete monthly intervals. Each participant contributed person-month observations until conception or censoring.

2.5. Statistical Analysis

Baseline characteristics were summarized as frequencies and percentages for categorical variables. Pregnancy rates within one year and two years were calculated according to categories of RBC folate status.
To identify key dietary contributors to folate status, multivariable linear regression models were fitted with log-transformed RBC folate concentration as the dependent variable. Results were expressed as percentage differences. p values were adjusted using the Benjamini–Hochberg false discovery rate (FDR) method.
Discrete-time proportional hazards models were implemented using a complementary log-log link logistic regression to estimate fecundability ratios (FRs) and 95% confidence intervals (CIs). FR represents the probability of conception in a given cycle among exposed versus unexposed individuals. An FR greater than 1 indicates higher fecundability (shorter time to pregnancy), whereas an FR less than 1 indicates reduced fecundability.
To explore potential time-dependent associations, additional analyses were conducted by administratively censoring follow-up at 6, 12, and 24 months. Participants who conceived beyond each time window were treated as censored at the corresponding cutoff.
Folate-related exposures were evaluated using a stepwise modeling strategy. First, each exposure, including FA supplementation, dietary folate intake, and RBC folate levels, was entered separately into multivariable models to estimate its independent association with fecundability. Subsequently, joint models were constructed to simultaneously include multiple exposure components. Model 1 included FA supplementation and the dietary folate frequency score. Model 2 further incorporated RBC folate levels. All models were adjusted for covariates, including age group, BMI group, residence, education, occupation, and passive smoking exposure. Follow-up time was additionally controlled for by including categorical time intervals in the models.
All statistical analyses were performed using R software (version 4.5.1). A two-sided p < 0.05 was considered statistically significant.

3. Results

A total of 1475 women were included in the analysis (Table 1). The majority were under 25 years old (69.2%), and 65.2% had a normal BMI (18.5–24 kg/m2). Over half had an education level of junior high school or below (58.8%), and 49.2% were farmers. Passive smoking exposure was reported by 38.6% of participants, and 69.3% resided in rural areas. Active smoking among women was uncommon in this cohort (0.7%). Notably, only 24 women (1.6%) reported FA supplementation at baseline, indicating that preconception supplementation was uncommon in this population during the study period.
Pregnancy rates according to RBC folate status are presented in Table 2. Within one year, 87.0% of women with RBC folate deficiency became pregnant, compared with 92.4% among those without deficiency (p = 0.045). At two years, the corresponding rates were 88.7% and 95.0% (p = 0.006).
Table 3 shows the associations between intake frequency of folate-rich foods and RBC folate concentrations. Fruit intake showed consistent positive associations, with increases of 12.77% (95% CI: 7.03, 18.83) for 4–6 times per week and 8.01% (95% CI: 3.38, 12.85) for ≥7 times per week, both remaining significant after FDR correction. Higher intake of root vegetables (≥7 times/week) and nuts (1–3 times/week) was also associated with increased RBC folate levels, with estimated increases of 9.42% (95% CI: 2.91, 16.35) and 6.73% (95% CI: 2.30, 11.35), respectively. Moderate intake of corn and seafood showed positive but non-significant associations after multiple comparison adjustment. No consistent associations were observed for other food groups.
In separate multivariable discrete-time models (Table 4), few individual exposures showed clear associations with fecundability. FA supplementation was not significantly associated with higher fecundability (overall FR = 1.27, 95% CI: 0.79, 1.93). Seafood intake of 1–3 times per week was associated with an FR of 1.23 (95% CI: 1.04, 1.44) overall, compared with intake less than once per week. No significant associations were observed for other foods, or the dietary folate frequency score. RBC folate non-deficiency (≥340 nmol/L) was also not significantly associated with fecundability (overall FR = 1.14, 95% CI: 0.93, 1.41).
Joint models simultaneously including multiple folate-related exposures are shown in Table 5. In Model 1, which included FA supplementation and the dietary folate frequency score, FA supplementation was associated with a higher FR within the first 6 months (FR = 1.73, 95% CI: 1.00, 2.76), although the overall estimate did not reach statistical significance (FR = 1.49, 95% CI: 0.92, 2.27). The dietary folate score was not associated with fecundability. In Model 2, which additionally included RBC folate status, the point estimates for FA supplementation were further increased. The FRs were 2.07 (95% CI: 1.01, 3.77) within 6 months, 1.91 (95% CI: 1.00, 3.30) within 12 months and within 24 months, with an overall FR of 1.89 (95% CI: 0.99, 3.27). RBC folate non-deficiency was not significantly associated with fecundability in this joint model (overall FR = 1.13, 95% CI: 0.92, 1.41).

4. Discussion

In this prospective cohort study of 1475 women without prior pregnancy, we examined the associations of FA supplementation, dietary folate intake, and RBC folate levels with fecundability. Several folate-rich foods were positively associated with RBC folate concentrations. However, in separate models, only seafood intake (1–3 times per week) was significantly associated with higher fecundability, while FA supplementation and RBC folate status were not. In joint models, positive associations were observed between FA supplementation and fecundability. Overall, these findings suggest that the association between folate and fecundability may be complex and encourage adequate folate intake during the preconception period.
Previous prospective cohort studies have reported positive associations between FA supplementation and fecundability. A study conducted in Singapore has reported that women who used FA supplements have higher fecundability compared with non-users (FR: 1.26, 95% CI: 1.03–1.56) [21]. Similarly, a prospective cohort study of 3895 Danish women planning pregnancy has shown that FA supplementation is associated with increased fecundability (FR:1.15, 95% CI: 1.06–1.25) [22]. In addition, higher folate intake, particularly from supplements, has been linked to improved reproductive outcomes, including higher ovarian reserve indicators and improved live birth rates following assisted reproductive technology treatment [28,29,30]. Several biological mechanisms may explain how folate could influence fertility. From a biological perspective, folate plays a central role in one-carbon metabolism, which is critical for DNA synthesis, repair, and methylation processes essential for oocyte quality, embryo development, and chromosomal stability [31]. Folate is also involved in homocysteine metabolism, and elevated homocysteine has been associated with oxidative stress, endothelial dysfunction, and impaired early embryonic development [32,33,34].
Despite these plausible mechanisms, epidemiological evidence remains inconsistent. Some studies, including systematic reviews and population-based analyses, have reported no significant associations between folate status and reproductive outcomes such as pregnancy rates, miscarriage, or assisted reproductive success [35,36,37,38,39]. Consistent with these studies, we did not observe a significant association between RBC folate status and fecundability after adjustment for potential confounders. Null findings have also been observed in specific populations, such as women with previous pregnancy loss and in folate-replete groups [23,24]. Results from large prospective cohort studies remain heterogeneous, with some suggesting modest associations between low dietary folate intake and reduced fecundability, but with inconsistent findings across populations [40]. Overall, the association between folate and fecundability appears complex.
Several factors may help explain our findings. First, the study was conducted during the early stage of FA supplementation policy implementation in China. Although FA supplementation showed associations with higher fecundability, its use in this cohort was low, limiting statistical precision. In addition, participants were recruited from women in northern China between 2009 and 2012. Therefore, the findings may not be fully generalizable to contemporary populations or to populations with different sociodemographic characteristics and FA supplementation practices. Second, the positive association with seafood intake may reflect overall dietary quality or socioeconomic factors, especially in Shanxi, where seafood consumption is generally low. Third, RBC folate concentrations were not associated with fecundability, which may be partly explained by relatively low and limited variability in folate levels in this population. Folate concentrations in this cohort were lower than those reported in populations with FA fortification and somewhat lower than levels observed in other regions of China [41,42], which may have reduced variability and the ability to detect associations. In addition, genetic variation, such as methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism affecting folate metabolism, may modify the association between folate and fertility [43]. Furthermore, fecundability is influenced by multiple factors including age, ovarian reserve, BMI, male fertility, and environmental exposures, which may have stronger effects on TTP than folate status alone.
From a public health perspective, this study provides insight into folate-related exposures among women planning their first pregnancy during the early stage of FA promotion in China. The use of FA supplementation was low in this cohort, indicating that preconception supplementation was not yet widely adopted during the study period. Although our findings do not provide strong evidence for an independent association between FA supplementation, dietary folate intake, RBC folate status, and fecundability, they support further continued attention to adequate folate intake among women planning pregnancy because of its established benefits for maternal and fetal health. In particular, premarital health examinations may provide an important opportunity to deliver folate-related health education and encourage the initiation of supplementation among women preparing for pregnancy. Future studies incorporating repeated biomarker measurements, more detailed assessment of supplement use, and larger numbers of supplement users are needed to further clarify the role of folate in fecundability.
This study has several strengths. First, the prospective cohort design ensured that folate-related exposures were assessed before conception, thereby reducing recall bias and minimizing the possibility of reverse causation, whereby women experiencing prolonged difficulty conceiving might subsequently modify their diet or initiate nutritional supplementation. In addition, participants were recruited according to predefined eligibility criteria, and major demographic and lifestyle factors were adjusted for in multivariable analyses to reduce potential selection bias and confounding. Second, multiple dimensions of folate exposure, including supplementation, dietary intake, and biomarker-based folate status, were evaluated simultaneously, allowing a more comprehensive assessment. Third, the study focused on women without prior pregnancy, which minimized potential confounding from reproductive history and improved the homogeneity of the study population.
Several limitations should be acknowledged. First, folate-related exposures were assessed only at baseline, and no information was available on changes in diet or FA supplementation during follow-up. Detailed information on FA dosage and food portion sizes was not collected, preventing quantitative assessment of total folate intake. In addition, FA supplementation and dietary intake were assessed using questionnaires specifically developed for the original cohort study. These instruments have been widely used within this cohort, and the observed associations between dietary intake measures and RBC folate concentrations provide indirect support for their ability to capture relevant folate-related exposures. Nevertheless, some degree of measurement error and recall bias cannot be excluded. Second, although analyses were adjusted for major demographic and lifestyle factors, fecundability is influenced by multiple determinants. Some potentially relevant factors, including detailed male fertility characteristics, reproductive health conditions, environmental exposures, and active smoking, were not systematically available. Finally, participants were recruited from two counties in Shanxi Province during 2009–2012, when FA supplementation during the preconception period was relatively uncommon. Therefore, the findings may not be fully generalizable to contemporary populations or to settings with different sociodemographic characteristics, dietary patterns, and folate supplementation practices.

5. Conclusions

In this prospective cohort of reproductive age women, a comprehensive assessment of folate-related exposures showed limited evidence of an association between folate and fecundability. Positive associations for FA supplementation were observed considering dietary intake and folate status. These findings are broadly consistent with current recommendations promoting adequate folate intake during the preconception period. Overall, this study provides foundational evidence on folate-related exposures and fecundability in a preconception cohort from northern China. Further studies with repeated exposure assessment and larger numbers of supplement users are needed to clarify the role of folate in fecundability.

Author Contributions

Conceptualization, J.L. (Jufen Liu), Z.L. (Zhizhen Liu) and Z.L. (Zhiwen Li); methodology, J.L. (Jianting Li), T.T. and X.J.; validation, L.N., X.L., L.W. and Y.W.; formal analysis, L.N.; investigation, L.N. and T.T.; resources, L.N., Y.Z., L.Z., Z.L. (Zhiwen Li) and J.L. (Jufen Liu); writing—original draft preparation, L.N.; writing—review and editing, L.N., T.T., X.J., X.L., L.W., Y.W., Y.Z., L.Z., J.L. (Jianting Li), Z.L. (Zhiwen Li), Z.L. (Zhizhen Liu) and J.L. (Jufen Liu); visualization, L.N. and T.T.; supervision, J.L. (Jufen Liu), Z.L. (Zhizhen Liu) and Z.L. (Zhiwen Li); project administration, J.L. (Jufen Liu), Z.L. (Zhizhen Liu) and Z.L. (Zhiwen Li). All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Key Research and Development Program, Ministry of Science and Technology of the People’s Republic of China (2025YFC2511501); Key Project of the Regional Innovation and Development Joint Fund, National Natural Science Foundation of China (U23A20420); Open Project Fund from Key Laboratory of Coal Environmental Pathogenicity and Prevention (Shanxi Medical University), Ministry of Education, China (MEKLCEPP/SXMU-202503); Open Project Fund from Department of Obstetrics and Gynecology, Peking University Third Hospital (BYSYSZKF2025003), Clinical Medicine Plus X—Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities (PKU2025PKULCXQ010).

Institutional Review Board Statement

The study was approved by the Institutional Review Board of Peking University (reference number: IRB0001052-09075 date of approval 29 October 2009 and reference number: IRB00001052-13060 19 November 2013).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding authors due to participant privacy and ethical review board requirements.

Acknowledgments

The authors thank the health care workers at the maternal and child health care centers of Shouyang and Xiyang for subject recruitment and data collection.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TTPTime to pregnancy
FAFolic acid
FRFecundability ratio
BMIBody mass index
RBCRed blood cell
ClsConfidence intervals

References

  1. Inhorn, M.C.; Patrizio, P. Infertility around the globe: New thinking on gender, reproductive technologies and global movements in the 21st century. Hum. Reprod. Update 2015, 21, 411–426. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Hong, X.; Yin, J.; Wang, W.; Zhao, F.; Yu, H.; Wang, B. The current situation and future directions for the study on time-to-pregnancy: A scoping review. Reprod. Health 2022, 19, 150. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Eisenberg, M.L.; Thoma, M.E.; Li, S.; McLain, A.C. Trends in time-to-pregnancy in the USA: 2002 to 2017. Hum. Reprod. 2021, 36, 2331–2338. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Rothman, K.J.; Wise, L.A.; Sørensen, H.T.; Riis, A.H.; Mikkelsen, E.M.; Hatch, E.E. Volitional determinants and age-related decline in fecundability: A general population prospective cohort study in Denmark. Fertil. Steril. 2013, 99, 1958–1964. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Scheike, T.H.; Rylander, L.; Carstensen, L.; Keiding, N.; Jensen, T.K.; Stromberg, U.; Joffe, M.; Akre, O. Time trends in human fecundability in Sweden. Epidemiology 2008, 19, 191–196. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Amoatey, P.; Al-Mayahi, A.; Omidvarborna, H.; Baawain, M.S.; Sulaiman, H. Occupational exposure to pesticides and associated health effects among greenhouse farm workers. Environ. Sci. Pollut. Res. Int. 2020, 27, 22251–22270. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Wildenschild, C.; Riis, A.H.; Ehrenstein, V.; Hatch, E.E.; Wise, L.A.; Rothman, K.J.; Sørensen, H.T.; Mikkelsen, E.M. Fecundability among Danish women with a history of miscarriage: A prospective cohort study. BMJ Open 2019, 9, e023996. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Sundaram, R.; Mumford, S.L.; Buck Louis, G.M. Couples’ body composition and time-to-pregnancy. Hum. Reprod. 2017, 32, 662–668. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  9. Hur, J.; West, K.P., Jr.; Shamim, A.A.; Rashid, M.; Labrique, A.B.; Wu, L.S.F.; Ali, H.; Ullah, B.; Schulze, K.J.; Klemm, R.D.W.; et al. Thinness and fecundability: Time to pregnancy after adolescent marriage in rural Bangladesh. Matern. Child Nutr. 2020, 16, e12985. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Wesselink, A.K.; Hatch, E.E.; Rothman, K.J.; Mikkelsen, E.M.; Aschengrau, A.; Wise, L.A. Prospective study of cigarette smoking and fecundability. Hum. Reprod. 2019, 34, 558–567. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Zhang, Y.; Gu, D.; Xie, Y.; Li, B. Sleep behaviors and time-to-pregnancy: Results from a Guangzhou City cohort. Reprod. Health 2025, 22, 141. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Sabbath, E.L.; Willis, M.D.; Wesselink, A.K.; Wang, T.R.; McKinnon, C.J.; Hatch, E.E.; Wise, L.A. Association between job control and time to pregnancy in a preconception cohort. Fertil. Steril. 2024, 121, 497–505. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Grieger, J.A.; Grzeskowiak, L.E.; Smithers, L.G.; Bianco-Miotto, T.; Leemaqz, S.Y.; Andraweera, P.; Poston, L.; McCowan, L.M.; Kenny, L.C.; Myers, J.; et al. Metabolic syndrome and time to pregnancy: A retrospective study of nulliparous women. Bjog 2019, 126, 852–862. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Showell, M.G.; Mackenzie-Proctor, R.; Jordan, V.; Hart, R.J. Antioxidants for female subfertility. Cochrane Database Syst. Rev. 2020, 8, Cd007807. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Ruder, E.H.; Hartman, T.J.; Reindollar, R.H.; Goldman, M.B. Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility. Fertil. Steril. 2014, 101, 759–766. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  16. Hanson, M.A.; Bardsley, A.; De-Regil, L.M.; Moore, S.E.; Oken, E.; Poston, L.; Ma, R.C.; McAuliffe, F.M.; Maleta, K.; Purandare, C.N.; et al. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: “Think Nutrition First”. Int. J. Gynaecol. Obstet. 2015, 131, S213–S253. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. De-Regil, L.M.; Peña-Rosas, J.P.; Fernández-Gaxiola, A.C.; Rayco-Solon, P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst. Rev. 2015, 2015, Cd007950. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  18. World Health Organization. Periconceptional Folic Acid Supplementation to Prevent Neural Tube Defects. Available online: https://www.who.int/tools/elena/interventions/folate-periconceptional/ (accessed on 5 June 2026).
  19. Steegers-Theunissen, R.P.; Twigt, J.; Pestinger, V.; Sinclair, K.D. The periconceptional period, reproduction and long-term health of offspring: The importance of one-carbon metabolism. Hum. Reprod. Update 2013, 19, 640–655. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  20. Philips, E.M.; Kahn, L.G.; Jaddoe, V.W.V.; Shao, Y.; Asimakopoulos, A.G.; Kannan, K.; Steegers, E.A.P.; Trasande, L. First trimester urinary bisphenol and phthalate concentrations and time to pregnancy: A population-based cohort analysis. J. Clin. Endocrinol. Metab. 2018, 103, 3540–3547. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  21. Ku, C.W.; Ku, C.O.; Tay, L.P.C.; Xing, H.K.; Cheung, Y.B.; Godfrey, K.M.; Colega, M.T.; Teo, C.; Tan, K.M.L.; Chong, Y.S.; et al. Dietary supplement intake and fecundability in a Singapore preconception cohort study. Nutrients 2022, 14, 5110. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Cueto, H.T.; Riis, A.H.; Hatch, E.E.; Wise, L.A.; Rothman, K.J.; Sørensen, H.T.; Mikkelsen, E.M. Folic acid supplementation and fecundability: A Danish prospective cohort study. Eur. J. Clin. Nutr. 2016, 70, 66–71. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  23. DeVilbiss, E.A.; Mumford, S.L.; Sjaarda, L.A.; Connell, M.T.; Kim, K.; Mills, J.L.; Silver, R.M.; Schisterman, E.F. Preconception folate status and reproductive outcomes among a prospective cohort of folate-replete women. Am. J. Obstet. Gynecol. 2019, 221, 51.e1–51.e10. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. You, X.; Zhang, Z.; Xu, Y.; Yang, B.; Huang, S.; Zou, Y.; Zhao, F.; Feng, C.; Lao, H.; Yuan, H.; et al. Exploring the correlation between homocysteine, red blood cell folate and MTHFRC677T genotypes with female infertility. Biomark. Med. 2024, 18, 749–758. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Ma, R.; Wang, L.; Jin, L.; Li, Z.; Ren, A. Plasma folate levels and associated factors in women planning to become pregnant in a population with high prevalence of neural tube defects. Birth Defects Res. 2017, 109, 1039–1047. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  26. Ren, A.; Zhang, L.; Hao, L.; Li, Z.; Tian, Y.; Li, Z. Comparison of blood folate levels among pregnant Chinese women in areas with high and low prevalence of neural tube defects. Public Health Nutr. 2007, 10, 762–768. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. World Health Organization. Serum and Red Blood Cell Folate Concentrations for Assessing Folate Status in Populations. Available online: http://apps.who.int/iris/bitstream/10665/162114/1/WHO_NMH_NHD_EPG_15.01.pdf?ua=1 (accessed on 10 April 2026).
  28. Loy, S.L.; Ku, C.W.; Tiong, M.M.Y.; Ng, C.S.T.; Cheung, Y.B.; Godfrey, K.M.; Lim, S.X.; Colega, M.T.; Lai, J.S.; Chong, Y.S.; et al. Modifiable risk factor score and fecundability in a preconception cohort in Singapore. JAMA Netw. Open 2023, 6, e2255001. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  29. Kadir, M.; Hood, R.B.; Mínguez-Alarcón, L.; Maldonado-Cárceles, A.B.; Ford, J.B.; Souter, I.; Chavarro, J.E.; Gaskins, A.J. Folate intake and ovarian reserve among women attending a fertility center. Fertil. Steril. 2022, 117, 171–180. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Gaskins, A.J.; Afeiche, M.C.; Wright, D.L.; Toth, T.L.; Williams, P.L.; Gillman, M.W.; Hauser, R.; Chavarro, J.E. Dietary folate and reproductive success among women undergoing assisted reproduction. Obstet. Gynecol. 2014, 124, 801–809. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  31. Laanpere, M.; Altmäe, S.; Stavreus-Evers, A.; Nilsson, T.K.; Yngve, A.; Salumets, A. Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability. Nutr. Rev. 2010, 68, 99–113. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  32. Cetin, I.; Berti, C.; Calabrese, S. Role of micronutrients in the periconceptional period. Hum. Reprod. Update 2010, 16, 80–95. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Di Simone, N.; Maggiano, N.; Caliandro, D.; Riccardi, P.; Evangelista, A.; Carducci, B.; Caruso, A. Homocysteine induces trophoblast cell death with apoptotic features. Biol. Reprod. 2003, 69, 1129–1134. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Skoracka, K.; Ratajczak, A.E.; Rychter, A.M.; Dobrowolska, A.; Krela-Kaźmierczak, I. Female fertility and the nutritional approach: The most essential aspects. Adv. Nutr. 2021, 12, 2372–2386. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  35. Paffoni, A.; Reschini, M.; Noli, S.A.; Viganò, P.; Parazzini, F.; Somigliana, E. Folate Levels and Pregnancy Rate in Women Undergoing Assisted Reproductive Techniques: A Systematic Review and Meta-analysis. Reprod. Sci. 2022, 29, 341–356. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  36. Gindler, J.; Li, Z.; Berry, R.J.; Zheng, J.; Correa, A.; Sun, X.; Wong, L.; Cheng, L.; Erickson, J.D.; Wang, Y.; et al. Folic acid supplements during pregnancy and risk of miscarriage. Lancet 2001, 358, 796–800. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  37. Murto, T.; Skoog Svanberg, A.; Yngve, A.; Nilsson, T.K.; Altmäe, S.; Wånggren, K.; Salumets, A.; Stavreus-Evers, A. Folic acid supplementation and IVF pregnancy outcome in women with unexplained infertility. Reprod. Biomed. Online 2014, 28, 766–772. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  38. Murto, T.; Kallak, T.K.; Hoas, A.; Altmäe, S.; Salumets, A.; Nilsson, T.K.; Skoog Svanberg, A.; Wånggren, K.; Yngve, A.; Stavreus-Evers, A. Folic acid supplementation and methylenetetrahydrofolate reductase (MTHFR) gene variations in relation to in vitro fertilization pregnancy outcome. Acta Obstet. Gynecol. Scand. 2015, 94, 65–71. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  39. Haggarty, P.; McCallum, H.; McBain, H.; Andrews, K.; Duthie, S.; McNeill, G.; Templeton, A.; Haites, N.; Campbell, D.; Bhattacharya, S. Effect of B vitamins and genetics on success of in-vitro fertilisation: Prospective cohort study. Lancet 2006, 367, 1513–1519. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  40. Cueto, H.T.; Jacobsen, B.H.; Laursen, A.S.D.; Riis, A.H.; Hatch, E.E.; Wise, L.A.; Trolle, E.; Sørensen, H.T.; Rothman, K.J.; Wesselink, A.K.; et al. Dietary folate intake and fecundability in two preconception cohorts. Hum. Reprod. 2022, 37, 828–837. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  41. Castaño, P.M.; Aydemir, A.; Sampson-Landers, C.; Lynen, R. The folate status of reproductive-aged women in a randomised trial of a folate-fortified oral contraceptive: Dietary and blood assessments. Public Health Nutr. 2014, 17, 1375–1383. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  42. Li, M.; Chen, X.; Zhang, Y.; Chen, H.; Wang, D.; Cao, C.; Jiang, Y.; Huang, X.; Dou, Y.; Wang, Y.; et al. RBC folate and serum folate, vitamin b-12, and homocysteine in Chinese couples prepregnancy in the Shanghai preconception cohort. J. Nutr. 2022, 152, 1496–1506. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  43. MacLean, C.A.; Dimanlig, M.; Godfrey, D.; Madrigal, L. The Fertility Effects of the C677T Mutation in the methylenetetrahydrofolate reductase gene: A cross-site systematic review and meta-analysis. Am. J. Hum. Biol. 2025, 37, e70119. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Table 1. Baseline characteristics of the study population (N = 1475).
Table 1. Baseline characteristics of the study population (N = 1475).
VariableFrequency (%)
Age
    <251020 (69.2)
      25–30386 (26.2)
    30–3558 (3.9)
      ≥3511 (0.7)
BMI (kg/m2)
    <18.5147 (10)
    18.5–24961 (65.2)
    ≥24356 (24.1)
    Missing11 (0.7)
Education
    Junior high school and below868 (58.8)
    High school and above607 (41.2)
Occupation
    Farmer726 (49.2)
    Worker117 (7.9)
    Other *632 (42.8)
Passive smoking
    No906 (61.4)
    Yes569 (38.6)
Active smoking
    No1465 (99.3)
    Yes10 (0.7)
Residence
    Rural1022 (69.3)
    Urban452 (30.6)
    Missing1 (0.1)
Folic acid supplementation
    No1432 (97.1)
    Yes24 (1.6)
    Missing19 (1.3)
* Other occupations included commercial workers, service personnel, technical staff, managerial personnel, and other occupations not classified elsewhere.
Table 2. Pregnancy rates within 1 and 2 years according to red blood cell folate status.
Table 2. Pregnancy rates within 1 and 2 years according to red blood cell folate status.
Red Blood Cell Folate Status1-Year Pregnancy Rate 2-Year Pregnancy Rate
PregnantTotalPregnancy Rate (%)pPregnantTotalPregnancy Rate (%)p
Deficiency (<340 nmol/L)10011587.00.04510211588.70.006
Non-deficiency (≥340 nmol/L)91999592.4 94199195.0
Table 3. Associations of individual folate-rich food intake frequencies with red blood cell folate concentrations: results from separate multivariable models.
Table 3. Associations of individual folate-rich food intake frequencies with red blood cell folate concentrations: results from separate multivariable models.
FoodFrequency (/Week)Estimate Effectp for FDR Correction
Corn<1 time1
1–3 times6.22 (1.16, 11.53)0.077
4–6 times2.38 (−8.15, 14.13)0.804
≥7 times11.40 (−3.22, 28.22)0.367
Leafy vegetables<1 time1
1–3 times−0.73 (−7.94, 7.04)0.849
4–6 times3.86 (−3.81, 12.14)0.513
≥7 times2.94 (−4.63, 11.12)0.653
Solanaceous vegetables<1 time1
1–3 times1.46 (−3.27, 6.41)0.696
4–6 times3.04 (−2.09, 8.45)0.501
≥7 times0.83 (−4.52, 6.48)0.821
Root vegetables<1 time1
1–3 times3.34 (−2.95, 10.04)0.513
4–6 times8.65 (1.89, 15.86)0.069
≥7 times9.42 (2.91, 16.35)0.031
Fresh legumes<1 time1
1–3 times2.11 (−1.21, 5.54)0.462
4–6 times2.48 (−2.31, 7.50)0.513
≥7 times4.58 (−2.03, 11.64)0.447
Soy products<1 time1
1–3 times−1.03 (−4.41, 2.46)0.696
4–6 times3.32 (−1.78, 8.68)0.462
≥7 times0.84 (−6.26, 8.47)0.849
Seafood<1 time1
1–3 times4.61 (0.20, 9.21)0.152
4–6 times5.09 (−5.14, 16.43)0.513
≥7 times2.06 (−10.14, 15.93)0.821
Eggs products<1 time1
1–3 times−1.62 (−6.44, 3.45)0.696
4–6 times4.03 (−1.22, 9.55)0.367
≥7 times0.96 (−4.40, 6.63)0.821
Fruits<1 time1
1–3 times4.92 (0.42, 9.63)0.137
4–6 times12.77 (7.03, 18.83)0.000
≥7 times8.01 (3.38, 12.85)0.009
Nuts and seeds<1 time1
1–3 times6.73 (2.30, 11.35)0.026
4–6 times8.32 (−0.17, 17.52)0.183
≥7 times3.56 (−3.65, 11.31)0.513
Note: Each food was analyzed in a separate linear regression model. All models were adjusted for age group, BMI group, residence, education, occupation, passive smoking exposure, and folic acid supplementation. RBC folate levels were natural log-transformed. Effect size represents percent change in RBC folate calculated as (exp(β) − 1) × 100%. FDR: false discovery rate.
Table 4. Associations of folate-related exposures with time to pregnancy: results from separate multivariable discrete-time models.
Table 4. Associations of folate-related exposures with time to pregnancy: results from separate multivariable discrete-time models.
Exposure VariablesnFRs (95% CI)
≤6 Months≤12 Months≤24 MonthsOverall
Folic acid supplementation
No14211111
Yes231.56 (0.91, 2.48)1.28 (0.77, 1.99)1.21 (0.73, 1.87)1.27 (0.79, 1.93)
Dietary intake
Corn
<1 time/week12401111
1–3 times/week1750.88 (0.71, 1.09)0.91 (0.75, 1.08)0.96 (0.80, 1.14)0.97 (0.81, 1.15)
4–6 times/week251.10 (0.63, 1.76)1.10 (0.68, 1.68)1.12 (0.70, 1.68)1.10 (0.69, 1.66)
≥7 times/week161.14 (0.57, 2.01)0.90 (0.48, 1.52)0.93 (0.51, 1.54)0.98 (0.55, 1.60)
Root vegetables
<1 time/week1041111
1–3 times/week3871.03 (0.78, 1.38)0.97 (0.77, 1.23)0.96 (0.76, 1.22)0.97 (0.78, 1.24)
4–6 times/week3191.06 (0.80, 1.43)0.96 (0.76, 1.23)0.95 (0.75, 1.21)0.96 (0.76, 1.23)
≥7 times/week6441.07 (0.82, 1.42)0.95 (0.76, 1.20)0.95 (0.76, 1.19)0.96 (0.77, 1.21)
Seafoods
<1 time/week12021111
1–3 times/week2011.29 (1.07, 1.55)1.24 (1.05, 1.46)1.23 (1.05, 1.44)1.23 (1.04, 1.44)
4–6 times/week321.19 (0.74, 1.79)1.26 (0.85, 1.79)1.28 (0.87, 1.81)1.27 (0.86, 1.79)
≥7 times/week210.85 (0.44, 1.47)0.73 (0.42, 1.18)0.85 (0.51, 1.31)0.83 (0.50, 1.28)
Fruits
<1 time/week2351111
1–3 times/week4010.90 (0.73, 1.12)0.98 (0.81, 1.17)1.00 (0.83, 1.20)0.99 (0.83, 1.19)
4–6 times/week2291.02 (0.80, 1.29)1.06 (0.86, 1.31)1.10 (0.90, 1.35)1.08 (0.88, 1.33)
≥7 times/week5901.01 (0.83, 1.25)1.08 (0.91, 1.29)1.10 (0.92, 1.31)1.08 (0.91, 1.29)
Nuts and seeds
<1 time/week11211111
1–3 times/week2131.10 (0.90, 1.32)1.11 (0.94, 1.30)1.11 (0.95, 1.30)1.10 (0.94, 1.29)
4–6 times/week521.32 (0.92, 1.82)1.11 (0.80, 1.50)1.22 (0.90, 1.62)1.21 (0.89, 1.61)
≥7 times/week670.87 (0.61, 1.21)0.95 (0.71, 1.24)0.97 (0.73, 1.25)0.96 (0.73, 1.24)
Dietary folate frequency score14461.01 (0.98, 1.04)1.01 (0.98, 1.04)1.01 (0.99, 1.04)1.01 (0.99, 1.04)
Red blood cell folate
Deficiency (<340 nmol/L)1241111
Non-deficiency (≥340 nmol/L)10631.09 (0.85, 1.40)1.13 (0.92, 1.40)1.14 (0.93, 1.41)1.14 (0.93, 1.41)
Note: Each exposure was analyzed in a separate multivariable discrete-time hazard model. Numbers do not sum to the total sample size because participants with missing values were excluded from each individual analysis. All models were adjusted for age group, BMI group, residence, education, occupation, and passive smoking exposure. FR: fecundability ratio; CI: confidence interval.
Table 5. Joint associations of folic acid supplementation, dietary folate frequency score, and red blood cell folate with time to pregnancy: results from multivariable discrete-time models.
Table 5. Joint associations of folic acid supplementation, dietary folate frequency score, and red blood cell folate with time to pregnancy: results from multivariable discrete-time models.
ModelExposure VariablesFRs (95% CI)
≤6 Months≤12 Months≤24 MonthsOverall
Model 1Folic acid supplementation
No1111
Yes 1.73 (1.00, 2.76)1.47 (0.88, 2.28)1.39 (0.84, 2.16)1.49 (0.92, 2.27)
Dietary folate frequency score1.01 (0.98, 1.05)1.01 (0.98, 1.04)1.01 (0.99, 1.04)1.01 (0.99, 1.04)
Model 2Folic acid supplementation
No1111
Yes 2.07 (1.01, 3.77)1.91 (1.00, 3.30)1.91 (1.00, 3.30)1.89 (0.99, 3.27)
Dietary folate frequency score1.01 (0.98, 1.04)1.01 (0.98, 1.04)1.01 (0.98, 1.04)1.01 (0.98, 1.04)
Red blood cell folate
Deficiency (<340 nmol/L)1111
Non-deficiency (≥340 nmol/L)1.09 (0.85, 1.41)1.13 (0.92, 1.41)1.13 (0.92, 1.41)1.13 (0.92, 1.41)
Note: Model 1 includes folic acid supplementation and dietary folate score. Model 2 additionally includes red blood cell folate levels. All models were adjusted for age group, BMI group, residence, education, occupation, and passive smoking exposure. FR: fecundability ratio; CI: confidence interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nie, L.; Tian, T.; Jia, X.; Lin, X.; Wang, L.; Wu, Y.; Zhang, Y.; Zhang, L.; Li, J.; Li, Z.; et al. Preconception Folate Status, Dietary Intake, Supplementation, and Time to Pregnancy Among Women in a Premarital Health Examination Cohort. Nutrients 2026, 18, 2238. https://doi.org/10.3390/nu18142238

AMA Style

Nie L, Tian T, Jia X, Lin X, Wang L, Wu Y, Zhang Y, Zhang L, Li J, Li Z, et al. Preconception Folate Status, Dietary Intake, Supplementation, and Time to Pregnancy Among Women in a Premarital Health Examination Cohort. Nutrients. 2026; 18(14):2238. https://doi.org/10.3390/nu18142238

Chicago/Turabian Style

Nie, Lirong, Tian Tian, Xiaoqian Jia, Xinyue Lin, Lingzhang Wang, Yuwei Wu, Yali Zhang, Le Zhang, Jianting Li, Zhiwen Li, and et al. 2026. "Preconception Folate Status, Dietary Intake, Supplementation, and Time to Pregnancy Among Women in a Premarital Health Examination Cohort" Nutrients 18, no. 14: 2238. https://doi.org/10.3390/nu18142238

APA Style

Nie, L., Tian, T., Jia, X., Lin, X., Wang, L., Wu, Y., Zhang, Y., Zhang, L., Li, J., Li, Z., Liu, Z., & Liu, J. (2026). Preconception Folate Status, Dietary Intake, Supplementation, and Time to Pregnancy Among Women in a Premarital Health Examination Cohort. Nutrients, 18(14), 2238. https://doi.org/10.3390/nu18142238

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop